Lily Yin WECKX
Biographic Data
| ID | 5620404 |
|---|---|
| NAME | Lily Yin WECKX |
| GIVEN NAMES | Lily Yin |
| FAMILY NAME | WECKX |
| SIGNATURE | WECKX L Y |
| AFFILIATIONS | Universidade Federal de São Paulo |
| ORCID | 0000-0003-4949-3582 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Experiência de implantação de um comitê estadual de farmacovigilância na pandemia de covid-19
The pharmacovigilance committee played a significant role in the ESAVI surveillance system during the period of analysis by assisting in the evaluation of more complex cases. It shows potential to contribute positively to strengthening the immunization program, especially within the safe vaccination system framework
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against Sars-CoV-2
Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Afri…
No prominent works on this page.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against Sars-CoV-2
Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Afri…
Experiência de implantação de um comitê estadual de farmacovigilância na pandemia de covid-19
The pharmacovigilance committee played a significant role in the ESAVI surveillance system during the period of analysis by assisting in the evaluation of more complex cases. It shows potential to contribute positively to strengthening the immunization program, especially within the safe vaccination system framework
2019-20 coronavirus outbreak (2 works) · Medicine (2 works) · Betacoronavirus (1 work) · Biology (1 work) · Clinical trial (1 work) · Coronavirus (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · Coronavirus disease 2019 (COVID-19) (1 work) · Coronavirus Infections (1 work) · COVID-19 Clinical Research Studies (1 work)